These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3021035)

  • 21. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.
    Connolly P; Wheat LJ; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2604-8. PubMed ID: 10991831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of systemic histoplasmosis in immunosuppressed mice with the triazole D0870.
    Clemons KV; Martinez M; Homola ME; Stevens DA
    J Med Vet Mycol; 1996; 34(4):241-6. PubMed ID: 8873882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of histoplasmosis.
    Mocherla S; Wheat LJ
    Semin Respir Infect; 2001 Jun; 16(2):141-8. PubMed ID: 11521246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
    Clemons KV; Martinez M; Calderon L; Stevens DA
    Antimicrob Agents Chemother; 2002 Mar; 46(3):922-4. PubMed ID: 11850289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic cavitary histoplasmosis. Failure of oral treatment with ketoconazole.
    Quinones CA; Reuben AG; Hamill RJ; Musher DM; Gorin AB; Sarosi GA
    Chest; 1989 Apr; 95(4):914-6. PubMed ID: 2924624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Generalized histoplasmosis due to Histoplasma duboisii with mediastino-pulmonary infection. Cure after 15 months of treatment with ketoconazole].
    Delclaux C; Schutz R; Calzolari M; Balloul E; Zango B
    Rev Mal Respir; 1992; 9(5):559-60. PubMed ID: 1439098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of murine pulmonary mucormycosis with SCH 42427, a broad-spectrum triazole antifungal drug.
    Goldani LZ; Sugar AM
    J Antimicrob Chemother; 1994 Feb; 33(2):369-72. PubMed ID: 8182030
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.
    Connolly P; Wheat J; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
    Antimicrob Agents Chemother; 1999 Feb; 43(2):322-8. PubMed ID: 9925526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole].
    Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT
    Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A clinical study of fluconazole in pulmonary aspergillosis].
    Yoneda R
    Jpn J Antibiot; 1989 Jan; 42(1):40-6. PubMed ID: 2540366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histoplasmosis: update 1998.
    Brooks JT; Wheat LJ
    AIDS Clin Care; 1998 Jan; 10(1):4-5. PubMed ID: 11365076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of interferon-gamma and amphotericin B for the treatment of systemic murine histoplasmosis.
    Clemons KV; Lutz JE; Stevens DA
    Microbes Infect; 2001 Jan; 3(1):3-10. PubMed ID: 11226849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic pulmonary histoplasmosis in the State of Rio de Janeiro, Brazil.
    Capone D; Wanke B; Monteiro PC; Lazéra MS; de Noronha Andrade G; do Valle AC; Moreno AM; Londero AT
    Mycopathologia; 1999; 145(2):75-9. PubMed ID: 10598067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations for the treatment of fungal pneumonias.
    Yamada H; Kotaki H; Takahashi T
    Expert Opin Pharmacother; 2003 Aug; 4(8):1241-58. PubMed ID: 12877634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fluconazole treatment of systemic mycoses].
    Mori T; Matsumura M; Ebe T; Takahashi M; Kohara T; Inagaki M; Isonuma H; Hibiya I; Hamamoto T; Watanabe K
    Jpn J Antibiot; 1989 Jan; 42(1):55-62. PubMed ID: 2540368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice.
    Cacciapuoti A; Loebenberg D; Parmegiani R; Antonacci B; Norris C; Moss EL; Menzel F; Yarosh-Tomaine T; Hare RS; Miller GH
    Antimicrob Agents Chemother; 1992 Jan; 36(1):64-7. PubMed ID: 1590702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. African histoplasmosis: report of two patients treated with amphotericin B and ketoconazole.
    Akpuaka FC; Gugnani HC; Iregbulam LM
    Mycoses; 1998 Nov; 41(9-10):363-4. PubMed ID: 9916457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute pulmonary histoplasmosis as an imported disease].
    van Crevel R; van der Ven AJ; Meis JF; Kullberg BJ
    Ned Tijdschr Geneeskd; 1997 Jun; 141(25):1242-4. PubMed ID: 9380167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis.
    LeMonte AM; Washum KE; Smedema ML; Schnizlein-Bick C; Kohler SM; Wheat LJ
    J Infect Dis; 2000 Aug; 182(2):545-50. PubMed ID: 10915087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.
    Wheat LJ; Connolly P; Smedema M; Durkin M; Brizendine E; Mann P; Patel R; McNicholas PM; Goldman M
    J Antimicrob Chemother; 2006 Jun; 57(6):1235-9. PubMed ID: 16627592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.